Logo
SearchSearch
Languages
Language
LoginSign up
Login
Invest in Sangamo Therapeutics Inc
Today
Create an eToro account to buy SGMO stock on a secure, user-friendly, multi-asset trading platform.
Buy Sangamo Therapeutics Inc
SGMO Price
Sangamo Therapeutics Inc SGMO
Buy SGMO

Trending stocks

See stocks with the biggest daily volume spikes vs. their 3-month average.

Sangamo Therapeutics Inc News

SGMO Price

Sangamo Therapeutics Inc SGMO

$2.240.01(0.45%)(1D)

SGMO Stock Price Chart

27.32%
Past Month
1D
1W
1M
6M
1Y
3Y
MAX
Sign up for full charts powered byTradingView logo
*Past performance is not an indication of future results
Asset positive trend

The Sangamo Therapeutics Inc share price is rising this week.

i
A ‘rising’ price indicates that the weekly price has increased by more than 0.5%.
A price ‘on the decline’ indicates that the weekly price has decreased by more than 0.5%.
A ‘stable’ price indicates that the change in weekly price is between -0.5% and 0.5%.
The Sangamo Therapeutics Inc share price today is 2.24, reflecting a 0.45% change over the last 24 hours and 21.99% over the past week. The current market capitalization of SGMO is 471.54M with an average volume in the last three months of 7.3M. The stock has a P/E ratio of -3.03 and a dividend yield of 0%. With the stock’s beta sitting at 1.68
Market Cap
i
Total value of all asset shares, calculated by multiplying the price by the total number of outstanding shares.
$471.54M
Day’s Range
i
Shows the high and low prices of the day.
1.77 - 2.8
52W Range
i
Shows the high and low prices of the last year.
0.27 - 3.15
Average Volume (3M)
i
The average number of shares traded per day over the last three months.
7.3M
Price-Earnings Ratio
i
The result of this asset’s share price divided by its earnings per share.
-3.03
Revenue
i
The total income generated by this company’s goods and services last year.
$52.29M
Dividend (Yield)
i
How much a company pays out in dividends each year relative to its stock price.
0 (0%)
Prev Close
i
The final price of this asset at the end of the last trading day.
$2.26
EPS
i
A company’s total earnings divided by the number of shares it has issued.
-0.74
Beta
i
A measure of whether any asset does, or doesn’t, experience price moves in line with the broader market.
1.68
What Is Sangamo Therapeutics Inc?
Sangamo Therapeutics Inc. is an American clinical-stage biotechnology company headquartered in Brisbane, California, with offices in Richmond California, the UK and France. The firm has a strong focus on genomic medicine and aims to move away from symptom-based treatments and apply cell and gene therapy to combat genetic diseases such as Haemophilia, Sickle Cell Disease, Fabry Disease and Multiple Sclerosis. The firm was founded in 1995.

The company’s lead product candidate is SB-525, a gene therapy for the treatment of Haemophilia A. The firm is also developing SAR445136, which is a cell therapy product candidate for the treatment of sickle cell disease. The firm is involved in various partnerships and collaborations with leading global pharmaceutical companies, which include partnering with Pfizer on research into gene therapy aimed at helping patients with Haemophilia.

Sangamo Therapeutics Inc. is engaged in research across the spectrum of genomic medicine, including gene and cell therapy clinical research, and pre-clinical programmes in genome engineering and off-the-shelf cell therapy. The firm is developing zinc finger technology, which involves using DNA-binding proteins to control gene expression and cell function. The firm is listed on the NASDAQ under the stock ticker SGMO.

Monitor the SGMO share price by adding it to your eToro watchlist.
Buy SGMO

How can I buy Sangamo Therapeutics Inc stocks?

To purchase Sangamo Therapeutics Inc:
01

Create an eToro account:

Sign up for an eToro account and verify your identity.
02

Deposit funds:

Deposit funds into your eToro account using your preferred payment method.
03

Search and purchase:

Search the Sangamo Therapeutics Inc (SGMO) page and place an order to buy Sangamo Therapeutics Inc.
Buy SGMO
Looking for more information? Check out our guide on Academy.
Top Guides
Our top picks for the most relevant guides from the eToro Academy
Top Dividend Stocks for 2024
Top Dividend Stocks for 2024
In times of market volatility, dividend investing provides investors with a steady source of income. eToro presents the top 6 dividend stocks to consider.
Read More
Stock Trading And Investing For Beginners
Stock Trading And Investing For Beginners
New to online trading? Learn the basics with eToro. What are stocks? trading vs. investing, what are the risks, and how to open a trade, step by step.
Read More
AI Stocks Poised for Growth in 2024
AI Stocks Poised for Growth in 2024
Gear up for 2024 with a focus on AI stocks. Dive into the promising growth of C3.ai, Palantir Technologies, CrowdStrike, through eToro's expert analysis.
Read More
Go to the Academy >
Graph
Buy Sangamo Therapeutics Inc
Invest in Sangamo Therapeutics Inc
Today
Create an eToro account to buy SGMO stock on a secure, user-friendly, multi-asset trading platform.
Buy SGMO

FAQ

The current price of SGMO is 2.24.
The average price target for Sangamo Therapeutics Inc is 2.24. Sign up to eToro for detailed analyst forecasts and price targets.
Analysts offer forecasts for Sangamo Therapeutics Inc based on market trends, financial reports and projected growth. Check the latest forecast for future price movements.
The market capitalisation of Sangamo Therapeutics Inc is 471.54M
Select the "1D" or "1W" timeframe on the eToro chart and zoom out to see the historical price movements of Sangamo Therapeutics Inc. The price of Sangamo Therapeutics Inc has ranged between 0.27 and 3.15 over the last year.
To buy SGMO, visit the "Sangamo Therapeutics Inc (SGMO)" page. Once you have created an account and deposited funds, click the "Trade" button and decide how much Sangamo Therapeutics Inc you want to purchase. You can also place an order that will buy SGMO at a specific price in the future.
Daily Movers
Today's biggest gainers and losers.
Buy SGMO
Scroll to top